Logo image of OPK

OPKO HEALTH INC (OPK) Stock Analyst Ratings

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.36  -0.02 (-1.81%)

After market: 1.36 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to OPK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.07. This target is 199.38% above the current price.
OPK was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OPK.
In the previous month the buy percentage consensus was at a similar level.
OPK was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
OPK Historical Analyst RatingsOPK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.362.023.064.078.93 - 48.53% 125.00% 199.38% 556.25%
OPK Current Analyst RatingOPK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-05-01 Barrington Research Maintains Outperform -> Outperform
2025-04-25 JP Morgan Initiate Neutral
2025-04-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-19 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-12 Barrington Research Maintains Outperform -> Outperform
2025-03-12 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-28 Barrington Research Maintains Outperform -> Outperform
2025-01-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-08 Barrington Research Maintains Outperform -> Outperform
2024-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-20 Barrington Research Maintains Outperform -> Outperform
2024-09-17 Piper Sandler Reiterate Overweight -> Overweight
2024-09-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-08 Barrington Research Maintains Outperform -> Outperform
2024-07-18 Piper Sandler Maintains Overweight -> Overweight
2024-05-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-01 Barrington Research Maintains Outperform -> Outperform
2024-04-01 Piper Sandler Reiterate Overweight -> Overweight
2024-02-28 Barrington Research Maintains Outperform -> Outperform
2024-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-29 Barrington Research Upgrade Market Perform -> Outperform
2023-05-05 HC Wainwright & Co. Reiterate Buy
2023-03-09 HC Wainwright & Co. Reiterate Buy
2023-02-24 HC Wainwright & Co. Reiterate Buy
2022-12-15 HC Wainwright & Co. Initiate Buy
2022-08-05 Piper Sandler Maintains Overweight
2022-05-10 Piper Sandler Maintains Overweight